Corbett Yolanda, Parapini Silvia, D'Alessandro Sarah, Scaccabarozzi Diletta, Rocha Bruno C, Egan Timothy J, Omar Aneesa, Galastri Laura, Fitzgerald Katherine A, Golenbock Douglas T, Taramelli Donatella, Basilico Nicoletta
Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano MI 20133, Italy.
University of Massachusetts Medical School, Division of Infectious Diseases, Massachusetts, MA 01605, USA; Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG 31270-901, Brazil.
Microbes Infect. 2015 Mar;17(3):184-94. doi: 10.1016/j.micinf.2014.11.001. Epub 2014 Nov 21.
In malaria, the evidence concerning the nucleotide-binding, oligomerization domain (NOD) 2 (NOD2) receptor is fragmented and the stimuli that might activate NOD2 are not well characterized. We investigated the role of NOD2 in vitro in the response of macrophages to Plasmodium falciparum products. Immortalized or primary bone marrow derived macrophages from wild type C57Bl/6 mice, or knockout mice for NOD2 or its adaptor proteins, were either primed with interferon gamma or left untreated, and stimulated with parasite products. Both lysates of infected erythrocytes or hemozoin induced higher levels of nitric oxide in primed than in unprimed wild type macrophages. When stimulated with hemozoin, primed macrophages knockout for NOD2, or for its adaptor proteins, produced significantly lower nitric oxide levels compared to wild type cells. Differently from hemozoin, the use of β-hematin (synthetic hemozoin) as stimulus showed that NOD2 is dispensable. Furthermore, the production of inflammatory cytokines by wild type cells treated with hemozoin was not dependent on NOD2. These data indicate that parasite components present in the hemozoin, differently from β-hematin, induce the production of nitric oxide through the activation of NOD2, whereas the production of inflammatory cytokines, like TNF-α or MIP-2 (CXCL2), seems to be NOD2 independent.
在疟疾中,关于核苷酸结合寡聚化结构域(NOD)2受体的证据并不完整,且可能激活NOD2的刺激因素尚未得到充分表征。我们在体外研究了NOD2在巨噬细胞对恶性疟原虫产物反应中的作用。来自野生型C57Bl/6小鼠、NOD2基因敲除小鼠或其接头蛋白基因敲除小鼠的永生化或原代骨髓来源巨噬细胞,要么用γ干扰素预处理,要么不进行处理,然后用寄生虫产物进行刺激。感染红细胞的裂解物或疟色素均能诱导预处理后的野生型巨噬细胞产生比未预处理时更高水平的一氧化氮。当用疟色素刺激时,NOD2基因敲除或其接头蛋白基因敲除的预处理巨噬细胞产生的一氧化氮水平明显低于野生型细胞。与疟色素不同,使用β-血红素(合成疟色素)作为刺激物表明NOD2并非必需。此外,用疟色素处理的野生型细胞产生炎性细胞因子并不依赖于NOD2。这些数据表明,疟色素中存在的寄生虫成分与β-血红素不同,通过激活NOD2诱导一氧化氮的产生,而炎性细胞因子如肿瘤坏死因子-α或MIP-2(CXCL2)的产生似乎不依赖于NOD2。